deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT01094132

Combined Digital Colposcopy Analysis to Improve Cervical Precancer and Cancer Detection (MDC_Algo)

Development and Application of a Multispectral Digital Colposcopy Algorithm for Detection of Cervical Intraepithelial Neoplasia and Neoplasia.

Sponsor: British Columbia Cancer Agency

Conditions Cervical Cancer Precancerous Condition
Interventions Multispectral Digital Colposcope (MDC)
Updated 8 times since 2017 Last updated: Jul 2, 2019 Started: Dec 31, 2012 Primary completion: Sep 1, 2016 Completion: Nov 9, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01094132, this PHASE2 trial focuses on Cervical Cancer and Precancerous Condition and remains completed. Sponsored by British Columbia Cancer Agency, it has been updated 8 times since 2012, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Oct 2017 · 8 months · monthly snapshotTerminated~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotCompleted~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshotCompleted~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Aug 2019 — Jan 2021 [monthly]

    Completed PHASE2

  5. Jun 2018 — Aug 2019 [monthly]

    Completed PHASE2

▶ Show 3 earlier versions

  1. Oct 2017 — Jun 2018 [monthly]

    Completed PHASE2

    Status: Terminated → Completed

  2. Feb 2017 — Oct 2017 [monthly]

    Terminated PHASE2

    Status: Recruiting → Terminated

  3. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

Dec 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • British Columbia Cancer Agency
  • Brookdale University Hospital Medical Center
  • M.D. Anderson Cancer Center
  • National Cancer Institute (NCI)
  • Texas Tech University Health Sciences Center
  • The University of Texas Health Science Center, Houston
  • William Marsh Rice University
Data source: British Columbia Cancer Agency

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations